A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
